Clinical Trial Update: Comparison of Repaglinide and Metformin Administered Alone or in Combination in Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing repaglinide and metformin administered alone or in combination in Type 2 diabetes has completed. The study was sponsored by Novo Nordi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Repaglinide (Repaglinide)
• metformin (metformin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED